Investigational Drug Information for Balovaptan
✉ Email this page to a colleague
What is the drug development status for Balovaptan?
Balovaptan is an investigational drug.
There have been 12 clinical trials for Balovaptan.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 8th 2018.
The most common disease conditions in clinical trials are Autism Spectrum Disorder, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
Summary for Balovaptan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 14 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2018-08-08) |
| Vendors | 33 |
Recent Clinical Trials for Balovaptan
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan | Hoffmann-La Roche | Phase 1 |
| Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at High Risk of Developing Malignant Brain Edema | Hoffmann-La Roche | Phase 2 |
| Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD) | Hoffmann-La Roche | Phase 2 |
Clinical Trial Summary for Balovaptan
Top disease conditions for Balovaptan
Top clinical trial sponsors for Balovaptan
US Patents for Balovaptan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
